A Pilot, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Tolerability, Safety, and Pharmacokinetics of a Single Intra-articular Injection of CNTX-0066 in Participants with Chronic, Moderate-to-Severe Osteoarthritis Knee Pain
Latest Information Update: 16 Mar 2026
At a glance
- Drugs CNTX 0066 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Centrexion Therapeutics
Most Recent Events
- 16 Mar 2026 New trial record